Lunit - Version SCOPE IO - AI-Powered Biomarker for Immuno-Oncology
Predicting immunotherapy outcome with AI analysis; Finding more responders to cancer treatment; Tissue Data is huge and complex; Complex is what AI does best.
-
Most popular related searches
Our Vision
Lunit is one of the few companies with high-level tissue data analysis technology. We provide not only detection of features, but link it to clinical outcomes, developing biomarkers specific to drugs.
How It Works
Generated by Lunit SCOPE IO
Detection & Quantification
Detects intratumoral TILs and stromal TILs from whole slide images.
3 Immune Phenotype Map Generation
Classifies three immune phenotypes—inflamed, excluded, desert.
AI Score & Cutoff
Calculates AI biomarker score based on the phenotype map. If the score is higher than the cut-off value, it indicates that the patient would be more likely to respond to immunotherapy.
How Our AI Works
STEP 1
Tissue Slide (FFPE)
Pre-treatment & H&E staining
STEP 2
Digitization using a scanner
Supports various scanner vendors
STEP 3
File upload to server
(both cloud or on-prem)
STEP 4
Lunit SCOPE IO analysis
Detection results for visualization
- Detection results for visualization
- Quantification results of key features detected
- Final score for response prediction
- Turnaround time: <10 min
*Lunit SCOPE IO is currently available for research use only
Customer reviews
No reviews were found for Lunit - Version SCOPE IO - AI-Powered Biomarker for Immuno-Oncology. Be the first to review!